Ava Nasrolahi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ava Nasrolahi has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Javad Mahmoudi
Tabriz Univ Med Sci, Neurosci Res Ctr NSRC, Tabriz, Iran
2 shared publications- Javad Mahmoudi
Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
2 shared publications Pouran Karimi
Tabriz Univ Med Sci, Neurosci Res Ctr NSRC, Tabriz, Iran
2 shared publications- Yao Yao
Department of Molecular Pharmacology and Physiology, Morsani College of Medicine University of South Florida Tampa Florida USA
2 shared publications - Ali Noori-Zadeh
Department of Clinical Biochemistry, Faculty of Allied Medical Sciences, Ilam University of Medical Sciences, Ilam, Iran
1 shared publication Fatemeh Farokhi-Sisakht
Tabriz Univ Med Sci, Neurosci Res Ctr NSRC, Tabriz, Iran
1 shared publication
Latest Publications
- 12 May 2026
- Published by Elsevier in Matrix Biology
- Vol. 146, 102015
Glycocalyx and basal lamina in neurological disorders
- 12 May 2026
- Published by Elsevier in Matrix Biology
- Vol. 146, 102015
Glycocalyx and basal lamina in neurological disorders
- 1 March 2025
- Published by Elsevier in Matrix Biology
- Vol. 137, 33-41
Laminins and the blood-brain barrier
- 1 March 2025
- Published by Elsevier in Matrix Biology
- Vol. 137, 33-41
Laminins and the blood-brain barrier
- 1 February 2024
- Published by Bentham Science Publishers Ltd. in Current Stem Cell Research & Therapy
- Vol. 19 (2) , 185-199
Stem Cell Therapy for the Treatment of Parkinson's Disease: What Promise Does it Hold?
Parkinson's disease (PD) is a common, progressive neurodegenerative disorder characterized by substantia nigra dopamine cell death and a varied clinical picture that affects older people. Although more than two centuries have passed since the earliest attempts to find a cure for PD, it remains an unresolved problem. With this in mind, cell replacement therapy is a new strategy for treating PD. This novel approach aims to replace degenerated dopaminergic (DAergic) neurons with new ones or provide a new source of cells that can differentiate into DAergic neurons. Induced pluripotent stem cells (iPSCs), mesenchymal stem cells (MSCs), neural stem cells (NSCs), and embryonic stem cells (ESCs) are among the cells considered for transplantation therapies. Recently disease-modifying strategies like cell replacement therapies combined with other therapeutic approaches, such as utilizing natural compounds or biomaterials, are proposed to modify the underlying neurodegeneration. In the present review, we discuss the current advances in cell replacement therapy for PD and summarize the existing experimental and clinical evidence supporting this approach.
- 1 February 2024
- Published by Bentham Science Publishers Ltd. in Current Stem Cell Research & Therapy
- Vol. 19 (2) , 185-199
Stem Cell Therapy for the Treatment of Parkinson's Disease: What Promise Does it Hold?
Parkinson's disease (PD) is a common, progressive neurodegenerative disorder characterized by substantia nigra dopamine cell death and a varied clinical picture that affects older people. Although more than two centuries have passed since the earliest attempts to find a cure for PD, it remains an unresolved problem. With this in mind, cell replacement therapy is a new strategy for treating PD. This novel approach aims to replace degenerated dopaminergic (DAergic) neurons with new ones or provide a new source of cells that can differentiate into DAergic neurons. Induced pluripotent stem cells (iPSCs), mesenchymal stem cells (MSCs), neural stem cells (NSCs), and embryonic stem cells (ESCs) are among the cells considered for transplantation therapies. Recently disease-modifying strategies like cell replacement therapies combined with other therapeutic approaches, such as utilizing natural compounds or biomaterials, are proposed to modify the underlying neurodegeneration. In the present review, we discuss the current advances in cell replacement therapy for PD and summarize the existing experimental and clinical evidence supporting this approach.
- 23 September 2021
- Published by Wiley in Biotechnology and Applied Biochemistry
- Vol. 69 (5) , 1942-1965
Stem cell‐based and mesenchymal stem cell derivatives for coronavirus treatment
Coronavirus disease 2019 (COVID-19) as one of the diseases pneumonia was first reported in Wuhan, China in December 2019. COVID-19 is considered the third most common coronavirus among individuals after acute respiratory syndrome (SARS-CoV) and the Middle East respiratory syndrome (MERS-CoV) in the 20th century. Many studies have shown that cell therapy and regenerative medicine approaches have an impressive effect on different dangerous diseases in a way that using a cell-based experiment could be effective for improving humans with severe acute respiratory infections caused by the 2019 novel coronavirus. Accordingly, due to the stunning effects of mesenchymal stem cells and derivatives on the treatment of various diseases, this review focuses on the auxiliary role of mesenchymal stem cells and their derivatives in reducing the inflammatory processes of acute respiratory infections resulted from the 2019 novel coronavirus. The reported MSCs treatment outcomes are significant because these cells prevent the immune system from over-activating and improve, endogenous repair by improving the lung microenvironment after the SARS-CoV-2 infection. The MSCs can be an effective, autologous, and safe treatment, and therefore, share the results. To date, the results of several studies have shown that mesenchymal stem cells and their derivatives can inhibit inflammation. Exosomes act as intercellular communication devices between cells for the transfer of active molecules. In this review, recent mesenchymal stem cells and their derivatives-based clinical trials for the cure of COVID-19 are introduced. This article is protected by copyright. All rights reserved
- 23 September 2021
- Published by Wiley in Biotechnology and Applied Biochemistry
- Vol. 69 (5) , 1942-1965
Stem cell‐based and mesenchymal stem cell derivatives for coronavirus treatment
Coronavirus disease 2019 (COVID-19) as one of the diseases pneumonia was first reported in Wuhan, China in December 2019. COVID-19 is considered the third most common coronavirus among individuals after acute respiratory syndrome (SARS-CoV) and the Middle East respiratory syndrome (MERS-CoV) in the 20th century. Many studies have shown that cell therapy and regenerative medicine approaches have an impressive effect on different dangerous diseases in a way that using a cell-based experiment could be effective for improving humans with severe acute respiratory infections caused by the 2019 novel coronavirus. Accordingly, due to the stunning effects of mesenchymal stem cells and derivatives on the treatment of various diseases, this review focuses on the auxiliary role of mesenchymal stem cells and their derivatives in reducing the inflammatory processes of acute respiratory infections resulted from the 2019 novel coronavirus. The reported MSCs treatment outcomes are significant because these cells prevent the immune system from over-activating and improve, endogenous repair by improving the lung microenvironment after the SARS-CoV-2 infection. The MSCs can be an effective, autologous, and safe treatment, and therefore, share the results. To date, the results of several studies have shown that mesenchymal stem cells and their derivatives can inhibit inflammation. Exosomes act as intercellular communication devices between cells for the transfer of active molecules. In this review, recent mesenchymal stem cells and their derivatives-based clinical trials for the cure of COVID-19 are introduced. This article is protected by copyright. All rights reserved
- Open Access
- 1 January 2020
- Vol. 12 (4) , 286-293
Cardioprotective effect of Rosa canina L. methanolic extract on heat shock induced cardiomyocyte injury: An experimental study
Introduction: Overexposure to heat conditions can affect the functioning of the cardiovascular system and may promote cardiovascular disorders. Heat shock induced myocardial injury via increasing endoplasmic reticulum response-mediated apoptosis. This study investigated the impact of pretreatment with Rosa canina (RC), a natural antioxidant, on myocardial damage induced by heat stress exposure and underlying mechanisms in cardiomyocytes in rats. Methods: Sixty adult male Wistar rats were allocated into five groups, including Control: received normal saline (NS), Heat Stress (HS), and HS+RC groups. Animals in the HS groups were subjected to heat stress (43 degrees C) for 15 minutes once a day for two weeks. Animals in the HS+RC groups received three doses of RC (250, 500, and 1000 mg/mL) one hour before being subjected to heat shock. The endoplasmic reticulum (ER) transmembrane kinases, including PKR-like endoplasmic reticulum kinase (PERK), immunoreactivity of CCAAT/enhancer-binding protein homologous protein (CHOP), and eukaryotic translation initiation factor 2-alpha (eIF2 alpha) as well as caspase 8 were detected by Western blot. The levels of reactive oxygen species (ROS) were assessed. Moreover, histopathological changes and apoptosis were also assayed in the heart tissue by using histopathological and TUNEL assays. Results: Heat exposure increased the level of ROS and induced oxidative damage in the heart tissue. The results demonstrated that RC administration decreased the overproduction of ROS induced by heat stress in cardiomyocytes. Moreover, heat stress upregulated the expression of p-PERK, p-eIF2 alpha, and CHOP protein while pretreatment with RC decreased expression of ER stress-related markers in cardiomyocytes. Besides, RC diminished heat stress-induced cellular damage and apoptosis associated with inhibition of caspase 8 activation, a pro-apoptotic protein in cardiomyocytes. Conclusion: These findings indicate that RC exerts a protective effect on heart tissue, at least in part, through inactivation of PERK/eIF2 alpha/CHOP pathway or inhibition of ER stress and oxidative stresstriggered apoptosis in cardiomyocytes induced by heat stress.
- 1 January 2020
- Vol. 12 (4) , 286-293
Open AccessCardioprotective effect of Rosa canina L. methanolic extract on heat shock induced cardiomyocyte injury: An experimental study
Introduction: Overexposure to heat conditions can affect the functioning of the cardiovascular system and may promote cardiovascular disorders. Heat shock induced myocardial injury via increasing endoplasmic reticulum response-mediated apoptosis. This study investigated the impact of pretreatment with Rosa canina (RC), a natural antioxidant, on myocardial damage induced by heat stress exposure and underlying mechanisms in cardiomyocytes in rats. Methods: Sixty adult male Wistar rats were allocated into five groups, including Control: received normal saline (NS), Heat Stress (HS), and HS+RC groups. Animals in the HS groups were subjected to heat stress (43 degrees C) for 15 minutes once a day for two weeks. Animals in the HS+RC groups received three doses of RC (250, 500, and 1000 mg/mL) one hour before being subjected to heat shock. The endoplasmic reticulum (ER) transmembrane kinases, including PKR-like endoplasmic reticulum kinase (PERK), immunoreactivity of CCAAT/enhancer-binding protein homologous protein (CHOP), and eukaryotic translation initiation factor 2-alpha (eIF2 alpha) as well as caspase 8 were detected by Western blot. The levels of reactive oxygen species (ROS) were assessed. Moreover, histopathological changes and apoptosis were also assayed in the heart tissue by using histopathological and TUNEL assays. Results: Heat exposure increased the level of ROS and induced oxidative damage in the heart tissue. The results demonstrated that RC administration decreased the overproduction of ROS induced by heat stress in cardiomyocytes. Moreover, heat stress upregulated the expression of p-PERK, p-eIF2 alpha, and CHOP protein while pretreatment with RC decreased expression of ER stress-related markers in cardiomyocytes. Besides, RC diminished heat stress-induced cellular damage and apoptosis associated with inhibition of caspase 8 activation, a pro-apoptotic protein in cardiomyocytes. Conclusion: These findings indicate that RC exerts a protective effect on heart tissue, at least in part, through inactivation of PERK/eIF2 alpha/CHOP pathway or inhibition of ER stress and oxidative stresstriggered apoptosis in cardiomyocytes induced by heat stress.
- 11 August 2019
- Published by Wiley in Experimental Physiology
- Vol. 104 (10) , 1544-1554
Rosa caninaL. methanolic extract prevents heat stress‐induced memory dysfunction in rats
New Findings: What is the central question of this study?Heat stress has harmful effects on the brain structure and synaptic density via induction of oxidative stress and neuroinflammation, which result in neuronal damage in the hippocampus and thereby cognitive impairments. In this study, we investigate the effect ofRosa caninatreatment on cognitive function in heat stress‐exposed rats and its underlying mechanisms. What is the main finding and its importance?We show thatR. caninaimproves cognitive deficits induced by heat stress by attenuation of oxidative stress and neuroinflammation and by upregulation of synaptic proteins in the hippocampus. The aim of the study was to evaluate the effects of aqueous methanolic extract ofRosa canina(RC) dried fruits on oxidative stress, inflammation, synaptic degeneration and memory dysfunction induced by heat stress (HS) in rats. Sixty adult male Wistar rats were randomly divided into five groups as follows: the control group received normal saline (NS); the HS group was exposed to heat stress (43°C) for 15 min once a day for 2 weeks; and HS+R groups were exposed to heat stress and received one of three doses (250, 500 or 1000 mg kg−1) of RC methanolic extract for 2 weeks. A passive avoidance test and a Y‐maze test were performed to assess learning and memory. The levels of reactive oxygen species were assessed. The serum cortisol concentration and hippocampal total antioxidant capacity, superoxide dismutase and glutathione peroxidase were also detected using spectrophotometry. The protein expressions of c‐Fos, heat‐shock protein‐70, tumour necrosis factor‐α, growth‐associated protein 43, post‐synaptic density‐95 and synaptophysin were evaluated in the hippocampal tissue. The results showed that RC significantly improved cognitive dysfunction induced by HS, which was accompanied by downregulation of tumour necrosis factor‐α and upregulation of growth‐associated protein 43 and synaptophysin proteins in the hippocampus of HS‐exposed rats. Furthermore, RC significantly attenuated serum cortisol concentrations and upregulated heat shock protein‐70 and c‐Fos in the hippocampus. In addition, the administration of RC attenuated reactive oxygen species levels and enhanced antioxidant defense in the hippocampus. These findings indicate that RC attenuated the deleterious effect of HS on cognition through its antioxidant properties and by enhancing synaptic function and plasticity.
- 11 August 2019
- Published by Wiley in Experimental Physiology
- Vol. 104 (10) , 1544-1554
Rosa caninaL. methanolic extract prevents heat stress‐induced memory dysfunction in rats
New Findings: What is the central question of this study?Heat stress has harmful effects on the brain structure and synaptic density via induction of oxidative stress and neuroinflammation, which result in neuronal damage in the hippocampus and thereby cognitive impairments. In this study, we investigate the effect ofRosa caninatreatment on cognitive function in heat stress‐exposed rats and its underlying mechanisms. What is the main finding and its importance?We show thatR. caninaimproves cognitive deficits induced by heat stress by attenuation of oxidative stress and neuroinflammation and by upregulation of synaptic proteins in the hippocampus. The aim of the study was to evaluate the effects of aqueous methanolic extract ofRosa canina(RC) dried fruits on oxidative stress, inflammation, synaptic degeneration and memory dysfunction induced by heat stress (HS) in rats. Sixty adult male Wistar rats were randomly divided into five groups as follows: the control group received normal saline (NS); the HS group was exposed to heat stress (43°C) for 15 min once a day for 2 weeks; and HS+R groups were exposed to heat stress and received one of three doses (250, 500 or 1000 mg kg−1) of RC methanolic extract for 2 weeks. A passive avoidance test and a Y‐maze test were performed to assess learning and memory. The levels of reactive oxygen species were assessed. The serum cortisol concentration and hippocampal total antioxidant capacity, superoxide dismutase and glutathione peroxidase were also detected using spectrophotometry. The protein expressions of c‐Fos, heat‐shock protein‐70, tumour necrosis factor‐α, growth‐associated protein 43, post‐synaptic density‐95 and synaptophysin were evaluated in the hippocampal tissue. The results showed that RC significantly improved cognitive dysfunction induced by HS, which was accompanied by downregulation of tumour necrosis factor‐α and upregulation of growth‐associated protein 43 and synaptophysin proteins in the hippocampus of HS‐exposed rats. Furthermore, RC significantly attenuated serum cortisol concentrations and upregulated heat shock protein‐70 and c‐Fos in the hippocampus. In addition, the administration of RC attenuated reactive oxygen species levels and enhanced antioxidant defense in the hippocampus. These findings indicate that RC attenuated the deleterious effect of HS on cognition through its antioxidant properties and by enhancing synaptic function and plasticity.
- 17 June 2019
- Published by Springer Nature in Current Pharmacology Reports
- Vol. 5 (4) , 219-231
Shared Pathological Mechanisms Between Diabetes Mellitus and Neurodegenerative Diseases
- 17 June 2019
- Published by Springer Nature in Current Pharmacology Reports
- Vol. 5 (4) , 219-231
Shared Pathological Mechanisms Between Diabetes Mellitus and Neurodegenerative Diseases